FIT Biotech
closedDevelops GTU technologies and product applications in DNA vaccination and immunogene therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
€43m (Public information from Jun 2015)
Company register number 0984183-4
Tampere Pirkanmaa (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€4.8m | Early VC | ||
| N/A | €3.6m Valuation: €43.2m | IPO | |
| Total Funding | €4.8m | ||
Recent News about FIT Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.